APA (7th ed.) Citation

Mullins, G. R., Hodsdon, M. E., Li, Y. G., Anglin, G., Urva, S., Schneck, K., . . . Calderon, B. (2024). Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies. The journal of clinical endocrinology and metabolism, 109(2), 361-369. https://doi.org/10.1210/clinem/dgad532

Chicago Style (17th ed.) Citation

Mullins, Garrett R., et al. "Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies." The Journal of Clinical Endocrinology and Metabolism 109, no. 2 (2024): 361-369. https://doi.org/10.1210/clinem/dgad532.

MLA (9th ed.) Citation

Mullins, Garrett R., et al. "Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies." The Journal of Clinical Endocrinology and Metabolism, vol. 109, no. 2, 2024, pp. 361-369, https://doi.org/10.1210/clinem/dgad532.